Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report)’s share price was up 1.4% on Thursday . The stock traded as high as $2.87 and last traded at $2.84. Approximately 7,951 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 19,017 shares. The stock had previously closed at $2.80.
Aytu BioPharma Stock Up 2.3 %
The company has a quick ratio of 0.91, a current ratio of 1.11 and a debt-to-equity ratio of 0.46. The stock’s fifty day simple moving average is $2.99 and its 200-day simple moving average is $2.82.
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last announced its earnings results on Wednesday, February 14th. The company reported ($0.04) EPS for the quarter. Aytu BioPharma had a negative net margin of 18.27% and a negative return on equity of 41.00%. The firm had revenue of $22.93 million during the quarter.
About Aytu BioPharma
Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.
Recommended Stories
- Five stocks we like better than Aytu BioPharma
- Using the MarketBeat Stock Split Calculator
- MarketBeat Week in Review – 4/22 – 4/26
- Transportation Stocks Investing
- 3 Stocks Leading the U.S. Agriculture Comeback
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
